Published Technical Disclosure Archive

Synergistic Prostate Cancer Treatment System

Publication ID: 24-11857243_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Prostate Cancer Treatment System,” Published Technical Disclosure No. 24-11857243_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857243_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,243.

Summary of the Inventive Concept

A novel system integrating heated condensable vapor technology with AI, IoT, blockchain, and machine learning to enhance prostate cancer treatment efficacy and patient outcomes.

Background and Problem Solved

The original patent's heated condensable vapor technology has limitations in optimizing treatment parameters, tracking patient outcomes, and ensuring data integrity. The new inventive concept addresses these limitations by synergistically combining the vapor technology with advanced technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The system comprises a vapor delivery device connected to an AI-powered vapor generator that optimizes vapor temperature and flow rate based on real-time tissue impedance feedback. The system integrates a blockchain-based patient data management system to track and verify treatment efficacy and patient outcomes. A needle-like vapor delivery device with a built-in IoT sensor monitors and transmits real-time treatment data to a remote monitoring station. The system also incorporates a machine learning algorithm that predicts optimal treatment parameters based on individual patient characteristics and medical history. Additionally, a novel nano-material based vapor generator enhances vapor temperature and stability, and is integrated with a real-time monitoring system.

Novelty and Inventive Step

The new claims introduce a synergistic combination of advanced technologies that significantly enhance the original patent's heated condensable vapor technology. The inventive step lies in the integration of AI, IoT, blockchain, and machine learning to create a more effective and personalized prostate cancer treatment system.

Alternative Embodiments and Variations

Alternative embodiments could include using different AI algorithms, integrating with other medical devices, or incorporating additional sensors to monitor treatment efficacy. Variations could include adapting the system for treating other types of cancer or using different vapor delivery mechanisms.

Potential Commercial Applications and Market

The Synergistic Prostate Cancer Treatment System has significant commercial potential in the medical device industry, particularly in the areas of cancer treatment and personalized medicine. The system's ability to enhance treatment efficacy, track patient outcomes, and ensure data integrity could lead to widespread adoption in hospitals and clinics.

CPC Classifications

SectionClassGroup
A A61 A61B18/042
A A61 A61B8/0841
A A61 A61B18/04
A A61 A61B2018/00005
A A61 A61B2018/00011
A A61 A61B2018/00017
A A61 A61B2018/00023
A A61 A61B2018/00101
A A61 A61B2018/00547
A A61 A61B2018/00577
A A61 A61B2018/00642
A A61 A61B2018/00702
A A61 A61B2018/00744
A A61 A61B2018/00791
A A61 A61B2018/00821
A A61 A61B2018/044
A A61 A61B2018/048
A A61 A61B2090/378
A A61 A61B2090/3784
A A61 A61B2218/007

Field of Art

Medical device technologies for minimally invasive cancer treatment, specifically focused on prostate tissue ablation using targeted vapor delivery systems, requiring expertise in medical imaging, thermal treatment technologies, and interventional oncology

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional radiologist with advanced training in medical device design, thermal ablation techniques, and digital health technologies, possessing knowledge of medical sensor integration, AI-driven treatment optimization, and minimally invasive surgical techniques

Obviousness Rationale

A PHOSITA would recognize that integrating digital health technologies like AI, IoT, and machine learning with existing vapor-based prostate cancer treatment methods represents a predictable technological evolution. The core vapor delivery mechanism remains fundamentally consistent with the source patent, while the added technological layers provide enhanced monitoring and personalization. These technological extensions represent incremental improvements using well-established techniques in medical device design and digital health integration.

Obvious Combinations & Variations

Source Patent Element
Vapor delivery needle for targeted prostate tissue ablation
PTD Variation
AI-powered vapor generator with real-time tissue impedance feedback optimization
Obviousness Reasoning
Adaptive parameter control is a known technique in medical device design, and integrating sensor-based feedback with thermal treatment represents a predictable technological enhancement
Source Patent Element
Needle-based vapor delivery for localized prostate treatment
PTD Variation
IoT sensor integration for real-time treatment data monitoring and transmission
Obviousness Reasoning
Remote monitoring of medical procedures is a standard practice, and adding sensor capabilities to existing medical devices is a routine design optimization
Source Patent Element
Targeted vapor ablation of prostate tissue
PTD Variation
Machine learning algorithm predicting optimal treatment parameters based on patient characteristics
Obviousness Reasoning
Personalized treatment optimization using patient data is a well-established approach in precision medicine, representing an obvious extension of existing treatment methodologies
Source Patent Element
Heated condensable vapor delivery mechanism
PTD Variation
Nano-material based vapor generator enhancing temperature stability and performance
Obviousness Reasoning
Material science improvements in medical device components are routine, and using advanced materials to enhance existing technologies represents a predictable engineering solution
Source Patent Element
Localized prostate tissue treatment method
PTD Variation
Blockchain-based patient data management system for tracking treatment efficacy
Obviousness Reasoning
Secure medical data tracking is a known technological trend, and integrating blockchain with medical treatment systems represents an obvious technological convergence
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857243 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed prostate cancer treatment system variations obvious and lacking inventive step. The incremental technological enhancements, including AI optimization, IoT monitoring, and machine learning integration, represent predictable extensions of existing medical device design principles and do not constitute a non-obvious invention under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,243
TitleSystems and methods for treating prostate cancer
Assignee(s)Boston Scientific Scimed, Inc.